Researchers from the Spanish National Cancer Research Centre (CNIO), led by Jorge L. MartÃ*nez-Torrecuadrada from the Proteomics Unit, have demonstrated that the antibody-based blocking of ephrinB2, a protein involved in angiogenesis and lymphoangiogenesis, may represent an effective strategy...